Menu

Markets

Research

News

Learn
Paper trading
AI Chat
Get the app WatchlistsPortfoliosAlerts
Sign in

Pacific Biosciences of California, Inc. PACB

Set alert

Price alert · PACB

All alert types
2.35 USD -0.26 -9.98%

At close

2.39 +0.04 +1.82%

Pre-market · Nov 3, 7:17 AM ET

Bid
2.34 × 2
Ask
2.35 × 1
2.31 Day range 2.72
1.07 52-week range 3.44
YTD
+25.40%
1 year
+4.69%
Open
2.68
Prev close
2.61
Mkt cap
728.90M
Vol
9.10M
Avg vol
12.11M
EPS
-0.43
P/E
0.00
Div yield
0.00%
More statistics
Low
2.31
High
2.72
Forward P/E
-2.84
Beta
2.01
Short ratio
4.46
Inst. own
84.53%
Dividend
0.00
Ex-div date
50-d avg
2.01
200-d avg
2.02
1y target
3.02

MAX chart

Chart tools
Interval
1m5m15m30m

Events in this range
  • Aug 2, 2023Earnings: -0.26; estimate -0.34; surprise 23.53%
  • Aug 7, 2024Earnings: -0.2; estimate -0.24; surprise 16.67%
  • Nov 7, 2024Earnings: -0.17; estimate -0.2; surprise 15%
Signals (46)
NameDateAgo
SMA: BullishSep 1, 20262 months ago
SMA: BullishSep 1, 20262 months ago
SMA: BearishMar 1, 20268 months ago
SMA: BullishOct 1, 20251 year ago
MACD: Buy SignalFeb 1, 20251 year ago
MACD: Sell SignalJan 1, 20242 years ago
MACD: Buy SignalDec 1, 20232 years ago
MACD: Sell SignalOct 1, 20233 years ago
SMA: BearishSep 1, 20233 years ago
MACD: Buy SignalApr 1, 20233 years ago
SMA: BullishOct 1, 20224 years ago
SMA: BearishJan 1, 20224 years ago
MACD: Sell SignalNov 1, 20215 years ago
SMA: BearishSep 1, 20215 years ago
RSI: OverboughtSep 1, 20206 years ago
SMA: BullishAug 1, 20206 years ago
SMA: BullishAug 1, 20206 years ago
MACD: Buy SignalAug 1, 20206 years ago
SMA: BearishJan 1, 20206 years ago
MACD: Sell SignalSep 1, 20197 years ago

Newest 20 of 46.

Analyst view

Consensus: buy

Buy
Price target (mean) 3.02 +28.8% upside
Target (low)
2.00
Target (mean)
3.02
Target (high)
6.00
Ratings (0m) 15 7 buy · 8 hold · 0 sell
  • Strong buy1
  • Buy6
  • Hold8
  • Sell0
  • Strong sell0

Recommendation trend

  • This month 15
  • 1 month ago 15
  • 2 months ago 14
  • 3 months ago 14

Earnings and revenue estimates

Consensus for the coming quarters and fiscal years

PACB analyst estimates
PeriodEPS estimateLow – highYear agoEPS growthRevenue estimateRevenue growthAnalysts
Current quarter-0.17551-0.21 – -0.11-0.27+35.0%40.66M-30.3%11
Next quarter-0.15903-0.19227 – -0.13-0.26+38.8%42.54M+9.6%8
Current year-0.81244-0.89123 – -0.74-1.11+26.8%155.49M-22.5%12
Next year-0.63882-0.74484 – -0.54-0.81244+21.4%191.23M+23.0%12

Upgrades and downgrades

The latest rating changes

PACB analyst upgrades and downgrades
DateFirmActionFromTo
Nov 11, 2024UBSDowngradeBuyNeutral
Nov 11, 2024ScotiabankMaintainedSector OutperformSector Outperform
Nov 11, 2024Piper SandlerMaintainedNeutralNeutral
Aug 28, 2024ScotiabankMaintainedSector OutperformSector Outperform
Aug 13, 2024Stephens & Co.MaintainedOverweightOverweight
Aug 12, 2024Morgan StanleyMaintainedEqual-WeightEqual-Weight
Aug 8, 2024Cantor FitzgeraldReiteratedOverweightOverweight
Aug 8, 2024Canaccord GenuityMaintainedBuyBuy
Jun 3, 2024JefferiesInitiated—Buy
May 15, 2024Morgan StanleyMaintainedEqual-WeightEqual-Weight
May 13, 2024Piper SandlerMaintainedNeutralNeutral
May 10, 2024BarclaysMaintainedEqual-WeightEqual-Weight
Apr 22, 2024JP MorganDowngradeOverweightNeutral
Apr 19, 2024Goldman SachsMaintainedNeutralNeutral
Apr 18, 2024BernsteinMaintainedOutperformOutperform
Apr 18, 2024Goldman SachsDowngradeBuyNeutral
Apr 18, 2024ScotiabankMaintainedSector OutperformSector Outperform
Apr 17, 2024TD CowenMaintainedBuyBuy
Apr 10, 2024BarclaysMaintainedEqual-WeightEqual-Weight
Apr 10, 2024Goldman SachsMaintainedBuyBuy
Mar 22, 2024Canaccord GenuityMaintainedBuyBuy
Feb 16, 2024UBSMaintainedBuyBuy
Dec 14, 2023GuggenheimInitiated—Neutral
Dec 14, 2023Stephens & Co.Initiated—Overweight
Dec 13, 2023Wolfe ResearchInitiated—Peer Perform
Nov 17, 2023UBSUpgradeNeutralBuy
Nov 6, 2023Piper SandlerMaintainedNeutralNeutral
Oct 31, 2023Canaccord GenuityMaintainedBuyBuy
Oct 31, 2023Cantor FitzgeraldUpgradeNeutralOverweight
Oct 24, 2023Morgan StanleyMaintainedEqual-WeightEqual-Weight